What is the address of COIN MEDICAL CLINICAL RESEARCH CONSULTANCY?

The registered office of COIN MEDICAL CLINICAL RESEARCH CONSULTANCY is located at Bassebeekstraat 39, 9031 Gent.

Is COIN MEDICAL CLINICAL RESEARCH CONSULTANCY still active?

Yes. According to the CBE (31 October 2026) COIN MEDICAL CLINICAL RESEARCH CONSULTANCY is active, legal situation “Normale toestand”, started on 16 August 2012.

Is COIN MEDICAL CLINICAL RESEARCH CONSULTANCY registered on Peppol?

Yes, COIN MEDICAL CLINICAL RESEARCH CONSULTANCY is registered on the Peppol network with ID 0208:0848419903.

What is the enterprise number of COIN MEDICAL CLINICAL RESEARCH CONSULTANCY?

The enterprise number of COIN MEDICAL CLINICAL RESEARCH CONSULTANCY is BE0848419903.

When was COIN MEDICAL CLINICAL RESEARCH CONSULTANCY founded?

COIN MEDICAL CLINICAL RESEARCH CONSULTANCY was founded on 16 August 2012.

Who are the directors of COIN MEDICAL CLINICAL RESEARCH CONSULTANCY?

According to the 2025 annual accounts, the directors of COIN MEDICAL CLINICAL RESEARCH CONSULTANCY are: Meintje Hendrika Middendorp.

Is COIN MEDICAL CLINICAL RESEARCH CONSULTANCY a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 16 August 2012; 4 annual accounts filed, latest fiscal year 2025; 1 directors known from the annual account.

How much profit did COIN MEDICAL CLINICAL RESEARCH CONSULTANCY make in 2025?

COIN MEDICAL CLINICAL RESEARCH CONSULTANCY posted a profit after taxes of € 14,137 in financial year 2025.

What is the revenue of COIN MEDICAL CLINICAL RESEARCH CONSULTANCY?

As a small company, COIN MEDICAL CLINICAL RESEARCH CONSULTANCY is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 119,276.

COIN MEDICAL CLINICAL RESEARCH CONSULTANCY (Private Limited)

Q: What does COIN MEDICAL CLINICAL RESEARCH CONSULTANCY do?

COIN MEDICAL CLINICAL RESEARCH CONSULTANCY is registered with the CBE as active in: Activiteiten van adviesbureaus op het gebied van public relations en communicatie. Private Limited, started on 16 August 2012, 1 establishment.

Dossier COIN MEDICAL CLINICAL RESEARCH CONSULTANCY, printed on 31 October 2026 from databakkes.be/en/0848419903/coin-medical-clinical-research-consultancy. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Financials

Financial year 2025

COIN MEDICAL CLINICAL RESEARCH CONSULTANCY from Gent, company number BE0848419903, closed financial year 2025 with a result of € 14,137 after tax. For that financial year COIN MEDICAL CLINICAL RESEARCH CONSULTANCY recorded a gross margin of € 119,276 and equity of € 151,963. Compared with financial year 2023, the result moved from € 7,375 to € 14,137. Profitable, and profit is growing. The company holds a healthy buffer. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on April 21, 2026.

What it is worth Healthy

€ 151,963

▼ 13% vs 2023

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Growing

€ 14,137

▲ 92% vs 2023

Profit after tax over the fiscal year.

Cash in the bank

€ 20,998

▼ 14% vs 2023

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Pays out

€ 65,200 paid out

More than the year’s profit went to the shareholders; reserves fell.

People and assets in 2025

Full-time equivalents estimate The annual accounts report no full-time equivalents. A micro company with one active director is usually run by that person; this is an assumption, not a figure from the source.

≈ 1

No payroll staff. One director, so that person most likely runs the business.

Vehicles and equipment

€ 1,654

▼ 41% vs 2023

Book value of vehicles, furniture and equipment.

Debts at end 2025

Bank debt

None

No bank loans on the last day of the fiscal year.

Owed to suppliers

€ 6,427

▼ 84% vs 2023

Supplier invoices still open on the last day of the fiscal year.

Taxes

€ 21,075

▼ 13% vs 2023

Corporate tax and VAT still to pay. No wage debt: nothing outstanding to staff or social security.

Key figures per fiscal year Download key figures (CSV)
	2021	2022	2023	2025	Change 2023 → 2025
Gross margin	€ 23,798 Gross margin 2021: € 23,798 First fiscal year in the series	€ 70,413 Gross margin 2022: € 70,413 ▲ 196% vs 2021 (€ 23,798) Favourable step	€ 5,638 Gross margin 2023: € 5,638 ▼ 92% vs 2022 (€ 70,413) Unfavourable step	€ 119,276 Gross margin 2025: € 119,276 ▲ € 113,638 vs 2023 (€ 5,638) Favourable step	▲ € 113,638
Profit after taxes	€ 10,772 Profit after taxes 2021: € 10,772 First fiscal year in the series	€ 51,227 Profit after taxes 2022: € 51,227 ▲ € 40,454 vs 2021 (€ 10,772) Favourable step	€ 7,375 Profit after taxes 2023: € 7,375 ▼ 86% vs 2022 (€ 51,227) Unfavourable step	€ 14,137 Profit after taxes 2025: € 14,137 ▲ 92% vs 2023 (€ 7,375) Favourable step	▲ 92%
Equity	€ 142,395 Equity 2021: € 142,395 First fiscal year in the series	€ 188,121 Equity 2022: € 188,121 ▲ 32% vs 2021 (€ 142,395) Favourable step	€ 175,196 Equity 2023: € 175,196 ▼ 7% vs 2022 (€ 188,121) Unfavourable step	€ 151,963 Equity 2025: € 151,963 ▼ 13% vs 2023 (€ 175,196) Unfavourable step	▼ 13%
Total debts	€ 88,248 Total debts 2021: € 88,248 First fiscal year in the series	€ 124,082 Total debts 2022: € 124,082 ▲ 41% vs 2021 (€ 88,248) Unfavourable step	€ 138,741 Total debts 2023: € 138,741 ▲ 12% vs 2022 (€ 124,082) Unfavourable step	€ 61,501 Total debts 2025: € 61,501 ▼ 56% vs 2023 (€ 138,741) Favourable step	▼ 56%
Cash	€ 4,342 Cash 2021: € 4,342 First fiscal year in the series	€ 7,421 Cash 2022: € 7,421 ▲ 71% vs 2021 (€ 4,342) Favourable step	€ 24,450 Cash 2023: € 24,450 ▲ 229% vs 2022 (€ 7,421) Favourable step	€ 20,998 Cash 2025: € 20,998 ▼ 14% vs 2023 (€ 24,450) Unfavourable step	▼ 14%
Retained profit	€ 66,195 Retained profit 2021: € 66,195 First fiscal year in the series	€ 111,921 Retained profit 2022: € 111,921 ▲ 69% vs 2021 (€ 66,195) Favourable step	€ 98,996 Retained profit 2023: € 98,996 ▼ 12% vs 2022 (€ 111,921) Unfavourable step	€ 75,763 Retained profit 2025: € 75,763 ▼ 23% vs 2023 (€ 98,996) Unfavourable step	▼ 23%
Dividend	€ 0 Dividend 2021: € 0 First fiscal year in the series	€ 5,500 Dividend 2022: € 5,500 Unchanged (€ 0) Unchanged	€ 20,300 Dividend 2023: € 20,300 ▲ 269% vs 2022 (€ 5,500) Unchanged	€ 65,200 Dividend 2025: € 65,200 ▲ 221% vs 2023 (€ 20,300) Unchanged	▲ 221%
Bank debt	€ 70,000 Bank debt 2021: € 70,000 First fiscal year in the series	€ 70,000 Bank debt 2022: € 70,000 Unchanged (€ 70,000) Unchanged	€ 46,667 Bank debt 2023: € 46,667 ▼ 33% vs 2022 (€ 70,000) Favourable step	€ 0 Bank debt 2025: € 0 ▼ 100% vs 2023 (€ 46,667) Favourable step	▼ 100%
Balance sheet total	€ 230,642 Balance sheet total 2021: € 230,642 First fiscal year in the series	€ 312,204 Balance sheet total 2022: € 312,204 ▲ 35% vs 2021 (€ 230,642) Unchanged	€ 313,937 Balance sheet total 2023: € 313,937 ▲ 1% vs 2022 (€ 312,204) Unchanged	€ 213,465 Balance sheet total 2025: € 213,465 ▼ 32% vs 2023 (€ 313,937) Unchanged	▼ 32%

Key figures of COIN MEDICAL CLINICAL RESEARCH CONSULTANCY, fiscal years 2021 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.

What happened to COIN MEDICAL CLINICAL RESEARCH CONSULTANCY?

What happened at COIN MEDICAL CLINICAL RESEARCH CONSULTANCY in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Apr 21, 2026 New annual accounts for financial year 2025: profit of € 14,137 (▲ 92% vs 2023). Source: NBB ↗
Sep 11, 2012 New establishment in Gent. KBO
Aug 16, 2012 Start of the company according to the CBE. KBO

In short

From € 10,772 profit in 2021 to € 14,137 profit in 2025.

Paid € 44,318 in corporate taxes since 2021.

Best year ever: 2022, with € 51,227 profit.

Paid out € 91,000 in dividends to the owners in total.

Original PDFs at the National Bank ↗

Management

Meintje Hendrika Middendorp

COIN MEDICAL CLINICAL RESEARCH CONSULTANCY

Behind COIN MEDICAL CLINICAL RESEARCH CONSULTANCY is Meintje Hendrika Middendorp.

Directors

According to the 2025 annual accounts

Meintje Hendrika Middendorp

Director

Establishments

Establishment units

Physical locations of this company

Registered office

Bassebeekstraat 39

9031 Gent

Who else lives here?

A building full of entrepreneurs or one very busy letterbox? Another 1 companies are registered at this address.

All companies at this address →

RPO NucleoGenesis

€ 8,231 gross margin · 2023

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number

0848.419.903

VAT number

BE 0848.419.903

Registered office

Bassebeekstraat 39, 9031 Gent

Names & denominations

COIN MEDICAL CLINICAL RESEARCH CONSULTANCY · COIN MEDICAL CRC

Enterprise type

Rechtspersoon

Legal form

Private limited company

Legal situation

Normale toestand

Start date

16 August 2012

Peppol

Active · Active since 24 Nov 2025

Activities · NACE

Activiteiten van adviesbureaus op het gebied van public relations en communicatie

Adviesbureaus op het gebied van public relations en communicatie

Activiteiten van holdings

Handel in eigen onroerend goed

Holdings

View on CBE Public ↗ Annual accounts (NBB) ↗